uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Commentary: Isolated Stem Cells - Patentable as Cultural Artifacts?
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Centre for Research Ethics and Bioethics. (Centre for Bioethics)
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Centre for Research Ethics and Bioethics. (Centre for Bioethics)
Uppsala University, Disciplinary Domain of Humanities and Social Sciences, Faculty of Law, Department of Law.
2007 (English)In: Stem Cells, ISSN 1066-5099, E-ISSN 1549-4918, Vol. 25, no 6, 1507-1510 p.Article in journal (Refereed) Published
Abstract [en]

This article argues that an isolated embryonic stem cell basically represents a cultural artifact that has no equivalent to cells of the embryo, and that it is likely that the isolation of adult stem cells has a similar consequence. An isolated stem cell could thus be distinguished as something other than the stem cell existing as part of a human body. Since isolation of stem cells implies modification, product patents should, where the results carry enough novelty, inventive step, and potential for industrial application, as a matter of principle be a viable option for patent authorities. Questions of morality, which may affect the patentability, should also be viewed in light of the distinction between isolated result and body part. At the same time, it is essential that patent authorities do not accept broad patent claims that will be detrimental to research. Disclosure of potential conflicts of interest is found at the end of this article.

Place, publisher, year, edition, pages
2007. Vol. 25, no 6, 1507-1510 p.
Keyword [en]
Stem cells, Patent, Ethics
National Category
Medical and Health Sciences Law
Identifiers
URN: urn:nbn:se:uu:diva-33526DOI: 10.1634/stemcells.2006-0684ISI: 000246906500020PubMedID: 17347494OAI: oai:DiVA.org:uu-33526DiVA: diva2:61425
Available from: 2007-07-09 Created: 2007-07-09 Last updated: 2017-12-06Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=17347494&dopt=Citation

Authority records BETA

Hansson, Mats G.Helgesson, GertWessman, Richard

Search in DiVA

By author/editor
Hansson, Mats G.Helgesson, GertWessman, Richard
By organisation
Centre for Research Ethics and BioethicsDepartment of Law
In the same journal
Stem Cells
Medical and Health SciencesLaw

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 397 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf